Krka reports lower Jan-Sep profit on higher sales
Ljubljana, 16 November - Slovenia's pharma group Krka saw its net profit fall by 22% year-on-year to EUR 235.6 million in the first nine months of the year despite sales revenue rising by 8% to EUR 1.34 billion.
The rest of this news item is available to subscribers.
The news item consists of 1.563 characters (without spaces) or 338 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.